Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The operating margin is -174.65%.
Reported quarterly operating margin; no daily interpolation. Q4 FY2025 (2025-12-31): 0.00%.
OPERATING MARGIN
-174.65%
OPERATING MARGIN AVG TTM
0.00%
OPERATING MARGIN AVG 3Y
N/A
OPERATING MARGIN AVG 5Y
N/A
OPERATING MARGIN AVG 10Y
N/A
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 836 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
SL Science Holding Ltd
Market Cap
$855.16M
Operating Margin
-174.65%
TTM Avg
0.00%
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$859.52M
Operating Margin
-8.31%
TTM Avg
-16.09%
3Y Avg
-30.50%
5Y Avg
-38.64%
Market Cap
$857.94M
Operating Margin
42.63%
TTM Avg
28.06%
3Y Avg
-1.90%
5Y Avg
-7.11%
Market Cap
$845.02M
Operating Margin
-30.67%
TTM Avg
-52.06%
3Y Avg
-18.41%
5Y Avg
7.25%
Market Cap
$865.24M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$836.24M
Operating Margin
-43.83%
TTM Avg
-75.55%
3Y Avg
-37.77%
5Y Avg
-25.18%
Market Cap
$834.16M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$833.88M
Operating Margin
-69.75%
TTM Avg
-70.49%
3Y Avg
-9306.05%
5Y Avg
-9306.05%
Market Cap
$832.55M
Operating Margin
-1776.32%
TTM Avg
-888.16%
3Y Avg
-444.08%
5Y Avg
-444.08%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| SL Science Holding Ltd (SLBT) | $855.16M | -174.65% | 0.00% | N/A | N/A |
| SI-BONE, Inc. (SIBN)vs › | $859.52M | -8.31% | -16.09% | -30.50% | -38.64% |
| Rigel Pharmaceuticals, Inc. (RIGL)vs › | $857.94M | 42.63% | 28.06% | -1.90% | -7.11% |
| QuidelOrtho Corporation (QDEL)vs › | $845.02M | -30.67% | -52.06% | -18.41% | 7.25% |
| Corvus Pharmaceuticals, Inc. (CRVS)vs › | $865.24M | 0.00% | 0.00% | 0.00% | 0.00% |
| Monte Rosa Therapeutics, Inc. (GLUE)vs › | $836.24M | -43.83% | -75.55% | -37.77% | -25.18% |
| SpyGlass Pharma, Inc. Common Stock (SGP)vs › | $834.16M | 0.00% | 0.00% | 0.00% | 0.00% |
| Beta Bionics, Inc. (BBNX)vs › | $833.88M | -69.75% | -70.49% | -9306.05% | -9306.05% |
| Alumis Inc. (ALMS)vs › | $832.55M | -1776.32% | -888.16% | -444.08% | -444.08% |
| Pacific Biosciences of California, Inc. (PACB)vs › | $842.48M | -348.46% | -328.22% | -265.67% | -226.03% |
Gross Margin
35.3%
Operating Margin
-174.7%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2025-12-31 | 0.00% |
| 2025-06-30 | 0.00% |
| 2024-12-31 | 0.00% |
